Technical Assistance to Conduct Health Technology Assessment of Priority Medicines for Inclusion in the Philippine National Formulary - APW
WHO
Technical Assistance to Conduct Health Technology Assessment of Priority Medicines for Inclusion in the Philippine National Formulary - APW
Request for proposal
Reference:
WHO-HSS/2024/001/231465
Beneficiary countries:
Philippines
Registration level:
Basic
Published on:
15-Apr-2024
Deadline on:
27-Apr-2024 20:00 (GMT 8.00)
Description
The World Health Organization (WHO) is seeking offers for bidders to come into contractual agreement to provide technical assistance to perform health technology assessment of priority medicines for inclusion in the Philippine National Formulary through an Agreement Performance of Work (APW) contract.
Please use Tender Notice No. 231465 as subject to all submission. Only successful candidates will be contacted.
Please refer to attached RFP for details of the requirement.
Prem Prakash Chopra - wproungm@who.int
51291712
-
Venlafaxine hydrochloride
51292011
-
Fluoxetine
51292012
-
Fluoxetine hydrochloride
51292019
-
Citalopram hydrobromide
51292023
-
Escitalopram oxalate
51292027
-
Sertraline hydrochloride
51292908
-
Mirtazapine
51292921
-
Imipramine hydrochloride
51293002
-
Amitriptyline
51293012
-
Amitriptyline hydrochloride
51293402
-
Bupropion
51294001
-
Aprepitant
51294403
-
Aripiprazole
51294513
-
Paroxetine hydrochloride
85131500
-
Experimental medicine services
85131600
-
Medical ethics
85131700
-
Medical science and research
re-attached the RFP
Edited on:
17-Apr-2024 04:12
Edited by:
choprap@who.int
Edited spelling
Edited on:
16-Apr-2024 10:16
Edited by:
choprap@who.int